Who Is Affected? Employers and their workforces can benefit from understanding how medications impact productivity and well-being. Employees who experience severe side effects or ineffective treatments may have higher absenteeism, reduced efficiency, and increased health care costs.
Read more
Who Is Affected? Anyone who takes medication can benefit from understanding how their body processes drugs. Some people experience severe side effects, while others don’t get the full benefit of their prescriptions due to genetic differences.
Read more
Pharmacogenomics or PGx, is the study of how an individual’s genetic makeup influences their response to medications. Due to its relatively low cost and high clinical potential PGx has been at the forefront of personalized medicine for several years. As global healthcare incorporates new technologies, countries worldwide are now adopting PGx testing to optimize drug therapies, reduce adverse drug reactions, and improve patient outcomes. This blog explores how various nations have integrated PGx into their healthcare systems, highlighting achievements, challenges, and unique approaches.
Read more
PGx represents a transformative approach in cancer treatment that utilizes the genetic makeup of both the patient and their cancer to personalize and optimize their cancer therapy, while minimizing adverse effects. It is a crucial component of precision medicine, offering a more targeted process compared to traditional cancer treatments. In this blog, we’ll explore the history, principles, and applications of PGx in oncology, as well as its challenges and future prospects.
Read more